Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea
- PMID: 21862264
- DOI: 10.1016/j.anl.2011.07.007
Anti-microbial and therapeutic effects of modified Burow's solution on refractory otorrhea
Abstract
Objective: Burow's solution, which contains 13% aluminum acetate, has been shown to be effective against chronic otitis media. Since the preparation of Burow's solution is time-consuming, its rapid preparation method has been recently developed. In this study, we evaluated the therapeutic effects of the modified Burow's solution on refractory otorrhea in patients with chronic suppurative otitis and its anti-microbial activity in vitro.
Methods: Fourteen ears of 12 patients with chronic otitis media, granular myringitis, otitis externa and postoperative mastoid cavity problems were treated topically with cotton swab/ball soaked with modified Burow's solution or its four-fold diluted ear drops once a week. We then examined the antimicrobial spectrum of modified Burow's solution against clinical bacterial isolates from otorrhea and laboratory bacterial strains in vitro.
Results: In all ears, refractory otorrhea disappeared after 1-17 weeks treatment of modified Burow's solution with a mean of 5.4 weeks without apparent side-effects such as ototoxicity. Modified Burow's solution inactivated all Gram positive bacteria within 5min except Enterococcus species, all Gram negative bacteria including Pseudomonas aeruginosa within 30s and Candida albicans within 2min. In addition, modified Burow's solution inactivated MRSA completely within 5min, while 80.6% of MRSA survived even a 20-min contact with 0.3% ofloxacin.
Conclusion: These findings indicate that modified Burow's solution, in addition to bearing a broad antimicrobial activity, is as effective as the original Burow's solution in the treatment of chronic suppurative otitis.
Copyright © 2011 Elsevier Ireland Ltd. All rights reserved.
Similar articles
-
[Effects of Burow's solution as an ear drop on Intractable chronic suppurative diseases of the external ear canal and middle ear].Nihon Jibiinkoka Gakkai Kaiho. 2003 Jan;106(1):28-33. doi: 10.3950/jibiinkoka.106.28. Nihon Jibiinkoka Gakkai Kaiho. 2003. PMID: 12647321 Japanese.
-
The efficacy of Burow's solution as an ear preparation for the treatment of chronic ear infections.Otol Neurotol. 2004 Jan;25(1):9-13. doi: 10.1097/00129492-200401000-00002. Otol Neurotol. 2004. PMID: 14724484 Clinical Trial.
-
Use of a modified Burow's solution to treat canine otitis externa: A randomised comparative clinical study.Vet Rec. 2022 Feb;190(3):e503. doi: 10.1002/vetr.503. Epub 2021 Jun 6. Vet Rec. 2022. PMID: 34091924
-
The development of antibiotic resistant organisms with the use of ototopical medications.Otolaryngol Head Neck Surg. 2004 Mar;130(3 Suppl):S89-94. doi: 10.1016/j.otohns.2003.12.009. Otolaryngol Head Neck Surg. 2004. PMID: 15054367 Review.
-
Topical treatment for otorrhea: issues and controversies.J Otolaryngol. 2005 Aug;34 Suppl 2:S52-5. J Otolaryngol. 2005. PMID: 16076416 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical